Pfizer
- Business
Pfizer is included in the cohort of healthcare sector companies experiencing a rally in 2024.
Pfizer Inc. stock has faced a prolonged, year-long decline attributed to the faster-than-expected normalization of COVID product uptake rates in…
Read More » - Business
“Pfizer Bold Move: Shocking Antitrust Solution Revealed! Cancer Drug Donation Shakes Up $43 Billion Seagen Deal!”
On Tuesday, Pfizer (PFE.N) announced its agreement to donate the royalty rights from the sales of the cancer drug Bavencio…
Read More »
